In addition, xenografts with EV showed significant tumor shrinkage after treatment with rituximab in terms of tumor weight (P = .029) and tumor volume (P = .0019), whereas those with PDK4 OE did not have significantly reduced tumor weight (P = .158) or tumor volume (P = .083). This evidence concerns the gene PDK4 and neoplasm.